
Sign up to save your podcasts
Or
Double episode this week and then I'll be taking the holidays off. I decided to combine two trials of immunotherapy for secondary prevention of cardiovascular disease, the CANTOS trial (canakinumab vs. placebo) and the CIRT trial (methotrexate vs. placebo). It was a good opportunity to debunk both therapies and take a few pot shots at observational trials, "bioplausibility," and surrogate endpoints. Both papers are available on my box account here.
4.9
111111 ratings
Double episode this week and then I'll be taking the holidays off. I decided to combine two trials of immunotherapy for secondary prevention of cardiovascular disease, the CANTOS trial (canakinumab vs. placebo) and the CIRT trial (methotrexate vs. placebo). It was a good opportunity to debunk both therapies and take a few pot shots at observational trials, "bioplausibility," and surrogate endpoints. Both papers are available on my box account here.
318 Listeners
498 Listeners
125 Listeners
3,332 Listeners
1,105 Listeners
119 Listeners
195 Listeners
517 Listeners
350 Listeners
168 Listeners
71 Listeners
4 Listeners
174 Listeners
6 Listeners
19 Listeners